-
SCREEN EVERY ELIGIBLE PATIENT AT AVERAGE RISK FOR COLORECTAL CANCER (CRC)
ONE YES AT A TIMEOffering patients a choice in CRC screening matters. Cologuard is an effective, noninvasive CRC screening option for patients aged 45 years and older at average risk.1
See why choice matters -
The Effect of a Shared Decision-Making Process on Acceptance of
Colorectal Cancer Screening2Study data as published in Annals of Family Medicine in 2022
-
Katie Couric
Is on a Mission to Screen
Katie Couric, award-winning journalist and colorectal cancer screening advocate, is teaming up with Exact Sciences to highlight the urgent need to get patients screened for CRC.
